Opinion: Covid-19 is changing the game for health care companies and investors
Even as the health care industry has stepped up with an unprecedented response to the…
Category: Biotech
.jpg)
Opinion: Physician advocacy against police brutality: #ThisIsOurLaneToo
Last week we found ourselves sharing yet again — first with anger, then with despair…
Longtime executive Tony Coles on biotech, racism, and opportunities for change
The killing of George Floyd at the hands of a white Minneapolis police officer has…
How the world can avoid screwing up the response to Covid-19 again
Even as Americans fight (and even kill) over the country’s response to the Covid-19 pandemic,…
Listen: The killing of George Floyd, the drug industry’s response, and what comes next
We’re going to do something different on this episode of “The Readout LOUD,” STAT’s biotech…
STAT Plus: Wholesale drug prices — and net prices — keep falling for most drugs
Amid continued political pressure on the pharmaceutical industry, a new analysis finds that brand-name drug…
Lancet retracts major Covid-19 paper that raised safety concerns about malaria drugs
The Lancet, one of the world’s top medical journals, on Thursday retracted an influential study…
AstraZeneca lays out plan for producing 2 billion doses of Covid-19 vaccine, if it works
The drug giant AstraZeneca said Thursday that it has found partners to manufacture and distribute…
Opinion: Racism: The contagion in health care we need to eradicate
The virus persists in the bloodstream for years, often spanning generations. The warning signs aren’t…
STAT Plus: Inovio sues a key contract manufacturer as it races to develop a Covid-19 vaccine
As the race to develop a Covid-19 vaccine accelerates, Inovio Pharmaceuticals (INO) filed a lawsuit…
Bill Gates expresses disappointment with Trump’s WHO decision — and hopes it can be walked back
Philanthropist Bill Gates expressed disappointment with President Trump’s announcement that the United States would withdraw…
STAT Plus: Pharmalittle: Five Covid-19 vaccine makers chosen for Warp Speed project; Moderna CEO defends data release
Good morning, folks, and how are you today? We are doing just fine, thank you….
Opinion: Oxford, AstraZeneca Covid-19 deal reinforces ‘vaccine sovereignty.’ We need a people’s vaccine instead
Sovereignty, in its most distilled form, is the power to decide who will live and…
Watch: MIT engineers develop a system to help physicians get the most out of ventilators
The Covid-19 pandemic triggered ventilator shortages in hospitals around the world as clinicians rushed to treat…
Your boss wants you to take a Covid-19 test and track your symptoms. There’s software for that
As more employers reopen their offices, stores, and warehouses, a growing number of health tech…
STAT Plus: In a first for RNA-modifying drugs, AstraZeneca partners with startup Accent Therapeutics
Drug giant AstraZeneca is moving deeper into RNA-based therapies with a new partnership with the…
Handgun ownership vastly increases suicide risk, large study confirms
A large new study confirms what mental health experts and those who research firearms have…
STAT Plus: Recapping ASCO 2020, talking cancer therapy combinations, and looking to the future
Before it even started, ASCO 2020 was one for the books. Held virtually for the…
STAT Plus: Tiny Denmark saved lots of money on biosimilar Humira, while Americans are still paying big bucks
For those yearning for the day when biosimilars save the U.S. health care system huge…
Hydroxychloroquine does not prevent Covid-19 infection if exposed, study says
The malaria drug hydroxychloroquine did not help prevent people who had been exposed to others…
STAT Plus: Private insurance might provide some shield from insulin price hikes — but the picture of costs is complicated
Although the cost of insulin has risen dramatically over the years and prompted a political…
STAT Plus: Moderna released scant Covid-19 data to prevent a leak, CEO says
The biotech company Moderna invited the scrutiny of the world last month when it withheld…
WHO resuming hydroxychloroquine study for Covid-19, after reviewing safety concerns
The World Health Organization is resuming a clinical trial exploring whether the malaria drug hydroxychloroquine…
Video Chat: The ASCO Recap, Live!
Editor’s note: The livestream will be embedded below at 1 p.m. ET. The biggest meeting…
STAT Plus: Pharmalittle: FDA used ‘threadbare evidence’ to OK malaria drugs; GAO slams FDA’s supply-chain oversight, again
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
Opinion: Create a health impact fund to spur development and equitable use of a Covid-19 vaccine
Calls for rethinking our pharmaceutical innovation system are swirling in the headwinds and tailwinds of…
‘Which death do they choose?’: Many Black men fear wearing a mask more than the coronavirus
When the CDC issued guidelines in early March asking people to wear masks to prevent…
At Mayo Clinic, sharing patient data with companies fuels AI innovation — and concerns about consent
ROCHESTER, Minn. — The patients of Mayo Clinic, whether they know it or not, have…
Top medical journals raise concerns about data in two studies related to Covid-19
Two of the world’s leading medical journals on Tuesday expressed concern about potential flaws in…
STAT Plus: Lawmakers, government watchdog blast FDA for poor oversight of U.S. drug supply chain
WASHINGTON — A government watchdog blasted the Food and Drug Administration for fumbling its oversight…
STAT Plus: Innovent starts China’s first trial of a novel cancer immunotherapy
A version of this story appeared Tuesday in STAT China, a weekly guide to biopharma and…
Opinion: It’s time to bring generic drug manufacturing back to the U.S.
In a hearing Tuesday afternoon on Capitol Hill, policymakers will consider repatriating America’s drug supply…
STAT Plus: Pharmalittle: Stressed Americans cause a shortage of an antidepressant; Dems attack GOP candidates over malaria drug
Rise and shine, another busy day is on the way. And it feels particularly busy….
STAT Plus: Pfizer to invest up to $500M in public companies with drugs in the clinic
Pfizer, the world’s largest drug company, is going to try its hand at picking biotech…
.jpg)
Opinion: Covid-19 has exposed cracks in the global medicines supply chain. We need to fix them
The Covid-19 pandemic has upended the normal ways of doing everything from going to school…
Opinion: Optimism, not evidence, is driving America’s return-to-work strategy
Consensus seems to be emerging that businesses can safely reopen by checking the temperatures of…
Debate over hydroxychloroquine spills over from the White House to congressional campaigns
WASHINGTON — Five months ahead of the general election, Democrats are escalating their attacks against…
Opinion: My nightmare: Covid-19 meets racism meets the killing of a Black American by police
This is my nightmare: Covid-19 meets racism meets the killing of yet another Black person…
STAT Plus: Despite protest, industry group backs use of horseshoe crab blood to test for bacteria in drugs
After a lengthy review, the organization that sets manufacturing standards for drug makers will keep…
The 20 executives — and companies — to know in Chinese biotech
In China, biotechnology long lagged behind the industry in the West. Now, it’s advancing at…
Opinion: Cutting ties with WHO creates a scientific and leadership vacuum
In yet another example of brash finger-pointing, President Trump called out China last week as…
STAT Plus: ASCO 2020 takeaways: AstraZeneca does a star turn, KRAS fizzles, and cell therapy shows progress
The annual meeting American Society of Clinical Oncology (ASCO) concluded on Sunday. The closely-followed cancer…
STAT Plus: Pharmalittle: Fauci ‘didn’t like’ Moderna vaccine data release; Pfizer breast cancer drug suffers a setback
Good morning, everyone, and welcome to another working week. We hope the weekend respite, if…
Gilead’s remdesivir shows some benefit in patients with moderate Covid-19, new data show
Remdesivir, the drug developed as a treatment for Covid-19 by Gilead Sciences, helped patients with…
New research offers hope for a way through the blood-brain barrier, ‘the final frontier for drug delivery’
We’ve evolved elegant protections for our brains. Gray matter deftly avoids contact with most interlopers,…
Eli Lilly begins first human tests of an antibody drug against Covid-19
Researchers have begun testing what appears to be the first new medicine developed specifically against…
Opinion: Resident physicians should have a say in their working conditions
In Chicago’s South Loop, the nightly salutation to health care workers begins at 8 p.m.,…
She’s spent decades caring for dying patients. When her mom’s time came, Covid-19 kept them apart
When Sharon Levine picked up, the person on the other end was sobbing. It was…
Anthony Fauci on Covid-19 reopenings, vaccines, and moving at ‘warp speed’
Anthony Fauci, the director of the National Institute for Allergy and Infectious Diseases, has seen…
Opinion: By cutting ties with the World Health Organization, Trump endangers global public health
President Trump’s announcement on Friday that the United States will cut ties with the World…